Clinical Trial Update: ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders [NA]

View source ↗

Summary

Clinical trial update on ExAblate Transcranial MRgFUS for treatment-refractory movement disorders; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia
• Essential Tremor
• Holmes Tremor
• Huntington Disease
• Orofacial Dyskinesia
• Parkinson Disease
• Tardive Dyskinesia
• Wilson Disease

Snippet

Sponsor: InSightec | Conditions: Movement Disorders, Essential Tremor | NA | Status: ACTIVE_NOT_RECRUITING